Rare diseases
Investigational molecules
Locations
Back to Germany314 clinical trials in Regensburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyTesting Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
GermanyStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
GermanyA study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.
GermanyA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
GermanyA Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment
GermanyStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
GermanyA Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial
GermanyLong-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension
GermanyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyStudy of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo
GermanyStudy of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of targeted therapies for HR-positive and HER2-negative variants. Research extends to lymphoma and leukemia treatments, with particular emphasis on combination therapies.
Multiple studies are evaluating novel drug combinations and their impact on patient survival rates.
Research focusing on preventive treatments for atopic dermatitis in high-risk pediatric populations, evaluating the effectiveness of early intervention strategies.
Studies aim to establish new preventive protocols for childhood dermatological conditions.
Investigations into treatments for pulmonary arterial hypertension and lung fibrosis, with emphasis on novel therapeutic approaches and drug safety profiles.
Current trials are exploring innovative treatments for various respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
